PK-DB: pharmacokinetics database for individualized and stratified computational modeling

التفاصيل البيبلوغرافية
العنوان: PK-DB: pharmacokinetics database for individualized and stratified computational modeling
المؤلفون: Dimitra Eleftheriadou, Jan Grzegorzewski, Yannick Duport, Adrian Köller, Janosch Brandhorst, Kathleen Green, Florian Barthorscht, Sara De Angelis, Danny Yu Jia Ke, Matthias König
المصدر: Nucleic Acids Research
سنة النشر: 2020
مصطلحات موضوعية: Physiologically based pharmacokinetic modelling, caffeine elimination, Prescription Drugs, Databases, Factual, AcademicSubjects/SCI00010, Population, Biology, computer.software_genre, 030226 pharmacology & pharmacy, Drug Administration Schedule, 03 medical and health sciences, 0302 clinical medicine, Pharmacokinetics, population pharmacokinetics, Caffeine, Genetics, Humans, Database Issue, Drug Dosage Calculations, education, 030304 developmental biology, codeine, 0303 health sciences, education.field_of_study, Computational model, Clinical Trials as Topic, Models, Statistical, Data curation, Database, Dose-Response Relationship, Drug, Drug Administration Routes, Body Weight, Smoking, Area under the curve, Molecular Sequence Annotation, 500 Naturwissenschaften und Mathematik::570 Biowissenschaften, Biologie::570 Biowissenschaften, Biologie, Gene Ontology, Pharmacodynamics, Area Under Curve, computer, Data integration, Contraceptives, Oral, Half-Life
الوصف: A multitude of pharmacokinetics studies have been published. However, due to the lack of an open database, pharmacokinetics data, as well as the corresponding meta-information, have been difficult to access. We present PK-DB (https://pk-db.com), an open database for pharmacokinetics information from clinical trials. PK-DB provides curated information on (i) characteristics of studied patient cohorts and subjects (e.g. age, bodyweight, smoking status, genetic variants); (ii) applied interventions (e.g. dosing, substance, route of application); (iii) pharmacokinetic parameters (e.g. clearance, half-life, area under the curve) and (iv) measured pharmacokinetic time-courses. Key features are the representation of experimental errors, the normalization of measurement units, annotation of information to biological ontologies, calculation of pharmacokinetic parameters from concentration-time profiles, a workflow for collaborative data curation, strong validation rules on the data, computational access via a REST API as well as human access via a web interface. PK-DB enables meta-analysis based on data from multiple studies and data integration with computational models. A special focus lies on meta-data relevant for individualized and stratified computational modeling with methods like physiologically based pharmacokinetic (PBPK), pharmacokinetic/pharmacodynamic (PK/PD), or population pharmacokinetic (pop PK) modeling.
تدمد: 1362-4962
URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7157da6627881150be51da5cadcc7934
https://pubmed.ncbi.nlm.nih.gov/33151297
Rights: OPEN
رقم الانضمام: edsair.doi.dedup.....7157da6627881150be51da5cadcc7934
قاعدة البيانات: OpenAIRE